0001213900-22-080968.txt : 20221219
0001213900-22-080968.hdr.sgml : 20221219
20221219164931
ACCESSION NUMBER: 0001213900-22-080968
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HSU ERIC C
CENTRAL INDEX KEY: 0001817867
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 221471723
MAIL ADDRESS:
STREET 1: C/O INMED PHARMACEUTICALS INC.
STREET 2: SUITE 310 - 815 HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
X0306
4
2022-12-16
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001817867
HSU ERIC C
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
0
1
0
0
Sr. VP, Pre-Clinical Res/Dev
Employee Stock Option (Right to Buy)
1.78
2022-12-16
4
A
0
4200
0.00
A
2027-12-15
Common shares
4200
8878
D
The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
/s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu
2022-12-19